These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 9058805

  • 1. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
    Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH.
    J Immunol; 1997 Mar 15; 158(6):2713-22. PubMed ID: 9058805
    [Abstract] [Full Text] [Related]

  • 2. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN, Sharpe AH.
    J Immunol; 1998 Sep 15; 161(6):2762-71. PubMed ID: 9743334
    [Abstract] [Full Text] [Related]

  • 3. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X, Constant S, Jorritsma P, Bottomly K.
    J Immunol; 1997 Dec 15; 159(12):5956-63. PubMed ID: 9550393
    [Abstract] [Full Text] [Related]

  • 4. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
    Khayyamian S, Hutloff A, Büchner K, Gräfe M, Henn V, Kroczek RA, Mages HW.
    Proc Natl Acad Sci U S A; 2002 Apr 30; 99(9):6198-203. PubMed ID: 11983910
    [Abstract] [Full Text] [Related]

  • 5. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K, Neena K, Chitralekha KT, Arif AK, Tomar D, Rao DN.
    Int Immunopharmacol; 2004 Jan 30; 4(1):1-14. PubMed ID: 14975355
    [Abstract] [Full Text] [Related]

  • 6. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
    Foreman KE, Wrone-Smith T, Krueger AE, Nickoloff BJ.
    Clin Immunol; 1999 Jun 30; 91(3):345-53. PubMed ID: 10370381
    [Abstract] [Full Text] [Related]

  • 7. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
    Ozawa H, Aiba S, Nakagawa, Tagami H.
    Eur J Immunol; 1996 Mar 30; 26(3):648-52. PubMed ID: 8605933
    [Abstract] [Full Text] [Related]

  • 8. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
    Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M.
    J Immunol; 1995 Jan 01; 154(1):97-105. PubMed ID: 7527824
    [Abstract] [Full Text] [Related]

  • 9. IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells.
    Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD.
    J Immunol; 1997 Jan 15; 158(2):614-21. PubMed ID: 8992975
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L, Shevach EM.
    J Immunol; 1998 Dec 15; 161(12):6614-21. PubMed ID: 9862689
    [Abstract] [Full Text] [Related]

  • 11. Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.
    Subauste CS, de Waal Malefyt R, Fuh F.
    J Immunol; 1998 Feb 15; 160(4):1831-40. PubMed ID: 9469444
    [Abstract] [Full Text] [Related]

  • 12. Cross-regulation of CD86 by CD80 differentially regulates T helper responses from Mycobacterium tuberculosis secretory antigen-activated dendritic cell subsets.
    Balkhi MY, Latchumanan VK, Singh B, Sharma P, Natarajan K.
    J Leukoc Biol; 2004 May 15; 75(5):874-83. PubMed ID: 14966193
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma.
    van Rijt LS, Vos N, Willart M, Kleinjan A, Coyle AJ, Hoogsteden HC, Lambrecht BN.
    J Allergy Clin Immunol; 2004 Jul 15; 114(1):166-73. PubMed ID: 15241361
    [Abstract] [Full Text] [Related]

  • 15. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
    Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ.
    J Immunol; 1995 Mar 15; 154(6):2668-77. PubMed ID: 7533180
    [Abstract] [Full Text] [Related]

  • 16. Blockade of CD86 signaling facilitates a Th2 bias at the maternal-fetal interface and expands peripheral CD4+CD25+ regulatory T cells to rescue abortion-prone fetuses.
    Zhu XY, Zhou YH, Wang MY, Jin LP, Yuan MM, Li DJ.
    Biol Reprod; 2005 Feb 15; 72(2):338-45. PubMed ID: 15456701
    [Abstract] [Full Text] [Related]

  • 17. Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling.
    Tam RC, Lim C, Bard J, Pai B.
    J Immunol; 1999 Oct 01; 163(7):3709-17. PubMed ID: 10490966
    [Abstract] [Full Text] [Related]

  • 18. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host disease.
    Saito K, Yagita H, Hashimoto H, Okumura K, Azuma M.
    Eur J Immunol; 1996 Dec 01; 26(12):3098-106. PubMed ID: 8977310
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts.
    Pechhold K, Patterson NB, Craighead N, Lee KP, June CH, Harlan DM.
    J Immunol; 1997 May 15; 158(10):4921-9. PubMed ID: 9144510
    [Abstract] [Full Text] [Related]

  • 20. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M, Falkner DH, Morel PA.
    J Leukoc Biol; 2005 Sep 15; 78(3):656-64. PubMed ID: 15961574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.